News
-
Low flow taps increase germs
Monday | Feb 24 2025THE speed at which water flows from a tap can significantly impact the possible risk of infections spreading in hospital and aged-care settings, according to a new study led by FlindersUniversity.
-
Dispensary Corner 24 Feb 25
Monday | Feb 24 2025COUGH lozenges rarely have a palatable flavour - that's not really their intention anyway - but we all probably wish they would taste better.
-
US pharma Cosette to buy Mayne Pharma
Friday | Feb 21 2025AUSTRALIAN company Mayne Pharmaceuticals has agreed to be bought by US pharma Cosette for around A$672 million (PD breakingnews).
-
Paxlovid not helping vaccinated
Friday | Feb 21 2025RESEARCHERS have reported that despite a doubling of prescriptions for COVID antiviral Paxlovid (nirmatrelvir-ritonavir) in Canada in 2022, there was no corresponding decrease in hospitalisations or death rates among highly vaccinated olderadults.
-
APP Chair’s top tip
Friday | Feb 21 2025THE State of the Industry panel is always one of Kos Sclavos' favourite sessions at the APP Conference.
-
TGA approves new thyroid drug
Friday | Feb 21 2025THE TGA has approved Yorvipath (palopegteriparatide) for the treatment of chronic hypoparathyroidism in adults, the first and only medicine to be listed on the ARTG for thisindication.
-
-
PD breaking news – Mayne Pharma to be bought by Cosette
Friday | Feb 21 2025Australian pharma company Mayne Pharmaceuticals has agreed to be bought by US pharma Cosette for around.
-
PSA members endorse strategic acquisition
Thursday | Feb 20 2025MEMBERS of the Pharmaceutical Society of Australia (PSA) voted last night in support of the necessary constitutional changes to allow the acquisition of the Australasian College of Pharmacy (ACP) to goahead.
-
TaperMate now available in app stores
Thursday | Feb 20 2025AFTER years in development and testing, patient medication tool TaperMate is now available for download on Google Play and the Apple App Store.
